Abstract
Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases.
Shingo Nakayamada, Yosuke Okada, Kazuyoshi Saito and Yoshiya Tanaka
The Journal of Rheumatology January 2004, 31 (1) 163-166;
Shingo Nakayamada
Yosuke Okada
Kazuyoshi Saito
In this issue
The Journal of Rheumatology
Vol. 31, Issue 1
1 Jan 2004
Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases.
Shingo Nakayamada, Yosuke Okada, Kazuyoshi Saito, Yoshiya Tanaka
The Journal of Rheumatology Jan 2004, 31 (1) 163-166;